TG Therapeutics, Inc. (TGTX)

TG Therapeutics' Briumvi shows strong patient retention, driving analyst optimism despite a recent EPS miss. Recent social posts highlight potential undervaluation and positive developments in their Car-T therapy.

About TG Therapeutics, Inc.

TG Therapeutics, Inc. is a biopharmaceutical company focused on treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. uses the ticker $TGTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

TG Therapeutics, Inc. (TGTX) social dominance is up 79.09% from the previous week.
TG Therapeutics, Inc. (TGTX) creators is up 36.65% from the previous month.
TG Therapeutics, Inc. (TGTX) mentions is up 64.82% from the previous month.
TG Therapeutics, Inc. (TGTX) posts created is up 150% from the previous week.

Price: $29.10

Price 24-Hour Time-Series Raw Data
The current price action is a reaction to a mixed earnings report, with social posts indicating a potential rebound due to strong patient retention for Briumvi and analyst optimism, despite a missed EPS target. Some posts suggest the stock is undervalued.

24-Hour: 1.96% 7-Day: 0.15% 30-Day: -4.94%

1-Year High: $45.50 on 2025-04-30
1-Year Low: $26.40 on 2025-08-11

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
TG Therapeutics, Inc. (TGTX) is currently AltRank #773 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +56
[--] Month: [-----] +783
[--] Months: [-----] +621
[--] Year: [-----] +695
1-Year High: [-----] on 2026-02-05
1-Year Low: [--] on 2025-03-03

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-14
1-Year Low: [--] on 2025-12-09

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -30%
[--] Month: [-------] -23%
[--] Months: [---------] -74%
[--] Year: [----------] +8.80%
1-Year High: [-------] on 2025-05-05
1-Year Low: [-----] on 2025-12-14

Engagements by network (24h): News: [---] Reddit: [--] YouTube: [--] TikTok: [--] X: [-----]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +48%
[--] Month: [-----] +65%
[--] Months: [-----] -14%
[--] Year: [------] +26%
1-Year High: [---] on 2025-08-13
1-Year Low: [--] on 2025-12-21

Mentions by network (24h): News: [--] Reddit: [--] YouTube: [--] TikTok: [--] X: [---]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning TG Therapeutics, Inc. (TGTX) in the last [--] hours which is up 7% from [--] in the previous [--] hours Daily Average: [---]
[--] Week: [---] +19%
[--] Month: [---] +37%
[--] Months: [-----] -42%
[--] Year: [-----] +46%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-21

The most influential creators that mention TG Therapeutics, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@assaf_elharby	[--]	[-----]	[--]	[-----]
@Aboyosef45	[--]	[--]	[--]	[---]
@LayanAhmed5637	[--]	[--]	[--]	[---]
@OptionsAlertsAi	[--]	[---]	[--]	[---]
@OzzieChambers	[--]	[---]	[--]	[---]
@BuyTheUgly	[--]	[--]	[--]	[--]
@TradesProfits	[--]	[---]	[--]	[--]

Sentiment: 54%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 54%
Daily Average: 75%
[--] Week: 50% -4%
[--] Month: 47% -32%
[--] Months: 47% -36%
[--] Year: 47% -12%
1-Year High: 98% on 2025-07-08
1-Year Low: 25% on 2026-02-01

Most Supportive Themes:

Briumvi Patient Retention: (35%) Positive data regarding Briumvi's patient retention rates, exceeding expectations and aligning with industry benchmarks.
Azer-cel Car-T Therapy: (25%) Positive developments and data related to the Azer-cel Car-T therapy, indicating progress in its development and potential.
Analyst Optimism: (15%) Analysts express positive sentiment towards TG Therapeutics, with buy ratings and increased price targets reflecting confidence in the company's future.

Most Critical Themes:

EPS Miss: (10%) The company missed analyst expectations for Earnings Per Share (EPS) in the recent quarter, raising concerns about profitability despite revenue growth.

Social Dominance: 0.011%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.011%
Daily Average: 0.025%
[--] Week: 0.02% +0.0087%
[--] Month: 0.013% +0.0002999999999999999%
[--] Months: 0.013% -0.012%
[--] Year: 0.013% -0.034%
1-Year High: 0.108% on 2025-03-05
1-Year Low: 0.0041% on 2025-10-24

Market Dominance: 0.00523%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00523%
Daily Average: 0%
1-Year High: 0.245% on 2025-04-30
1-Year Low: 0.00523% on 2026-02-17

Market Cap: $4,613,549,646

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $4,613,549,646
Daily Average: $5,320,534,289
[--] Week: $4,613,549,646 -0.45%
[--] Month: $4,613,549,646 -4.90%
[--] Months: $4,613,549,646 +1.10%
[--] Year: $4,613,549,646 +0.60%
1-Year High: $7,225,909,231 on 2025-04-30
1-Year Low: $4,187,185,527 on 2025-08-11

Top TG Therapeutics, Inc. News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

"TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) Seeking Alpha TGTherapeutics is on track to beat expectations with Briumvi its fast-growing best-in-class MS treatment. Find out why TGTX stock is a Buy"
News Link @SeekingAlpha 2025-05-28T10:00Z 316.4K followers, [----] engagements

Top TG Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$TGTX $QNTM Hope in the Lab: A Drug to Protect Myelin Hope & Health with Mathew Embry Episode #020 featuring Quantum BioPharma $QNTM Watch the full episode: https://t.co/WYuGzaYDrM What does it really take to move a promising MS therapy from the lab to patients In Episode [--] of Hope in the Lab: A Drug to Protect Myelin Hope & Health with Mathew Embry Episode #020 featuring Quantum BioPharma $QNTM Watch the full episode: https://t.co/WYuGzaYDrM What does it really take to move a promising MS therapy from the lab to patients In Episode [--] of"
X Link @AngelicSurvivor 2026-02-17T16:40Z [---] followers, [---] engagements

"$NET $TGTX $TEM #_ #_ # https://x.com/messages/composerecipient_id=1823764140206272512 https://x.com/messages/composerecipient_id=1823764140206272512"
X Link @LayanAhmed5637 2026-02-17T14:30Z [--] followers, [---] engagements

"$TGTX Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis More Info: https://pryzm.ozmosi.com/product/8349 https://pryzm.ozmosi.com/product/8349"
X Link @OzmosiHealth 2026-02-17T14:03Z [----] followers, [---] engagements

"$SBEV ✈ $DVLT $UOKA $QBTS $BATL $OFAL $STSS $GLE $MASK $OTLK $NAMI $GOOGL $DIS $MARA $PTON $MELI $NET $TGTX $TEM $SOUN $NVO $TSLA $GOOG $WIFI $TRUMP #USA"
X Link @assaf_elharby 2026-02-17T09:56Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing